Big Pharma and Big Green - it's all about the money
COVID-19 vaccine makers stand to make billions of dollars after US health officials approved booster shots for older and vulnerable Americans while manufacturers' stock prices continue to rise during the pandemic.
The Centers for Disease Control late on Thursday endorsed third shots of the Pfizer vaccine for all Americans 65 and older, along with tens of millions of younger people at higher risk of coronavirus because of their health or jobs.
